Alexium International Group Limited

DB:E7T Stock Report

Market Cap: €9.7m

Alexium International Group Valuation

Is E7T undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of E7T when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate E7T's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate E7T's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for E7T?

Key metric: As E7T is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for E7T. This is calculated by dividing E7T's market cap by their current revenue.
What is E7T's PS Ratio?
PS Ratio1.7x
SalesUS$5.89m
Market CapUS$10.23m

Price to Sales Ratio vs Peers

How does E7T's PS Ratio compare to its peers?

The above table shows the PS ratio for E7T vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
BIG1 Bio-Gate
0.9x16.3%€6.5m
IBU IBU-tec advanced materials
0.6x19.2%€27.6m
LXS LANXESS
0.3x2.8%€2.1b
DLX Delignit
0.3x10.2%€23.1m
E7T Alexium International Group
1.7xn/a€15.7m

Price-To-Sales vs Peers: E7T is expensive based on its Price-To-Sales Ratio (1.7x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does E7T's PS Ratio compare vs other companies in the European Chemicals Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
E7T 1.7xIndustry Avg. 1.0xNo. of Companies31PS01.22.43.64.86+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: E7T is expensive based on its Price-To-Sales Ratio (1.7x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is E7T's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

E7T PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.7x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate E7T's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies